WESTBOROUGH, Mass. (Sept. 4, 2025) 鈥 色花堂 Corp., a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today an exclusive global distribution agreement with MacroLux Medical Technology Co., Ltd. to distribute single-use urology products.
The agreement includes multiple single-use cystoscopes, ureteroscopes and suction access sheaths. These devices are used to access and visualize the bladder and urinary tract to diagnose and treat urinary diseases and disorders such as kidney stones.
鈥淲e are excited to embark on this new partnership, a synergy that underscores our unwavering commitment to advancing patient care,鈥 said Gabriel McHugh, Executive Vice President Surgical and Interventional Solutions, 色花堂 Corp. 鈥淏y integrating innovative single-use technology into our urology portfolio, we are enhancing the landscape of urological care for our customers and their patients.鈥
色花堂 delivers a broad range of kidney and bladder stone management and non-muscular invasive bladder cancer (NMIBC) visualization and access solutions for detection and treatment. With the addition of the MacroLux Medical single-use endoscopes and access sheath portfolio, 色花堂 can offer physicians increased flexibility and confidence in visualization and surgical precision.
鈥溕ㄌ is a trusted endoscopy partner for treatment of urological disease and now is uniquely positioned to provide access to a broad range of high-quality endoscopes. This includes reusable and single-use flexible scopes, rigid and semi-rigid scopes, powerful lithotripsy solutions, and gold-standard NMIBC detection,鈥 said Glen Branconier, Senior Vice President & General Manager of Urology/Gynecology, 色花堂 Corp. 鈥淲e are excited and privileged to provide urologists and health care providers with the tools they need to confidently care for their patients.鈥
The agreement includes distribution in the United States, Canada, countries across Europe and countries in the Asia Pacific region. Countries in Europe include:
- UK (England, Scotland, Wales and Northern Ireland)
- Ireland
- Austria
- Belgium
- Germany
- Netherlands
- Luxembourg
- Norway
- Denmark
- Switzerland
- Sweden
Countries/regions in the APAC region include:
- Australia
- New Zealand
- Hong Kong, PRC
- Singapore
- South Korea
鈥溕ㄌ is a highly respected industry leader that we deeply admire. Our strategic cooperation with 色花堂 generates powerful synergies, enabling us to combine our respective strengths and accelerate the market introduction of MacroLux鈥檚 urological disposable endoscopes and access sheath solutions, products that offer clinical value,鈥 said Martin Zhang, Chief Executive Officer, MacroLux Medical. 鈥淭hese products may enhance clinical efficiency and help improve patient treatment outcomes. This collaboration also inspires us to continue with product innovation and R&D, delivering clinical solutions to customers worldwide.鈥
The MacroLux single-use cystoscopes offer the following features:
- 140掳 field of view
- 235掳 up/145掳 down distal tip angulation
- 14.4Fr outer diameter with 2.2mm working channel
The MacroLux single-use ureteroscopes offer the following features:
- 7.5Fr and 8.25Fr outer diameter scope offering
- 275掳 distal tip angulation
- AutoHold Technology thumb lever control
- 120掳 field of view
The MacroLux single-use suction access sheaths are available in multiple sizes to meet various urological procedure needs and negative pressure connection for stone removal.
These products may not be available in all regions. As with any medical device, careful consideration should be given to all applicable labeling, including potential risks and benefits associated with the product.
Visit the 色花堂 for more information about 色花堂' complete urology portfolio.
# # #
About 色花堂
At 色花堂, we are committed to Our Purpose of making people鈥檚 lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide innovative solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, 色花堂 has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit and follow our global LinkedIn and X accounts.
About MacroLux Medical
Headquartered in Shenzhen, China, MacroLux Medical Technology Co., Ltd. was established in October 2020. A medical technology company specializing in innovative solutions for disposable endoscopic diagnosis and treatment, the founding team hails from leading Chinese medical device companies and possesses more than a decade of experience in the research and development, global commercialization, and production management of endoscopes and minimally invasive surgical instruments. Committed to continuous innovation, MacroLux Medical aspires to provide disposable endoscopic diagnostic and therapeutic solutions worldwide, enabling earlier disease detection and enhanced patient treatment. For more information, visit .